India suffers from a high prevalence of diabetes and raised blood pressure. In this video, PASCAL GELDSETZER presents a detailed analysis of the prevalence of both conditions in India and asks how they might be better treated and controlled. Using population-based data collected by the Indian government, Geldsetzer shows that there is huge variation in the prevalence of these conditions between different Indian states and that these conditions do not, as is sometimes assumed, only affect the wealthier strata of Indian society. With evident relevance for health authorities in India, the work also provides food for thought for authorities considering health interventions in other low and middle-income countries worldwide.
DOI:
https://doi.org/10.21036/LTPUB10654

Researcher

Dr. Pascal Geldsetzer is based in the Department of Global Health and Population in the T.H. Chan School of Public Health at Harvard University. He received his medical degree from the University of Edinburgh in 2011. His main research focus is on how healthcare systems can most effectively respond to chronic conditions in low and middle-income countries. Geldsetzer’s research has received significant and repeated support from the largest, oldest and most prestigious German scholarship foundation, the Studienstiftung des deutschen Volkes. (https://scholar.harvard.edu/geldsetzer)

Original publication

Diabetes and Hypertension in India: A Nationally Representative Study of 1.3 Million Adults

Manne-Goehler Jennifer, Atun Rifat, Bärnighausen Till, Vollmer Sebastian, Geldsetzer Pascal, Theilmann Michaela, Davies Justine I., Awasthi Ashish and Jaacks Lindsay M.
JAMA Internal Medicine
Published in 2018

Geographic and Sociodemographic Variation of Cardiovascular Disease Risk in India: A Cross-sectional Study of 797,540 Adults

others, Manne-Goehler Jennifer, Bärnighausen Till, Vollmer Sebastian, Geldsetzer Pascal, Theilmann Michaela, Davies Justine I., Awasthi Ashish, Jaacks Lindsay M., Danaei Goodarz and Gaziano Thomas A.
PLoS Medicine
Published in 2018

Beyond